Parker Waichman LLP Wins Key Tasigna MDL Argument
On August 10, 2021, Parker Waichman LLP won a critical argument on behalf of plaintiffs who filed lawsuits alleging Tasigna® (Nilotinib) caused severe harm, including peripheral vascular disease, arterial damage [...]